Kinyip Gabriel Leung Net Worth

Kinyip Gabriel Leung biography

Kinyip Leung serves as Independent Director of the Company. Mr. Leung was the Vice Chairman of our Board and an employee of Novocure from 2011 to 2016, coordinating Novocure’s global commercial operations. From 2003 to 2010, he worked for OSI Pharmaceuticals, Inc. (“OSI”), a specialty pharmaceutical company, prior to its acquisition by Astellas Pharma Inc., last serving as executive vice president of OSI and the President of OSI’s Oncology and Diabetes Business. Prior to his tenure at OSI, from 1999 to 2003, Mr. Leung served as group vice president of the global prescription business at Pharmacia Corporation, a global pharmaceutical and healthcare company. From 1991 to 1999, Mr. Leung was an executive at Bristol-Myers Squibb Company, a global pharmaceutical and healthcare company. He has been Former director of Pernix Therapeutics Holdings, Inc. from 2016 to 2019; director of Albany Molecular Research Inc. from 2010 to 2016 and of Delcath Systems, Inc. from 2011 to 2014. He holds B.S. with High Honors, University of Texas at Austin; M.S. in Pharmacy (with a concentration in pharmaceutical marketing), University of Wisconsin-Madison.

What is the salary of Kinyip Leung?

As the Independent Director of NovoCure Ltd, the total compensation of Kinyip Leung at NovoCure Ltd is $389,970. There are 16 executives at NovoCure Ltd getting paid more, with William Doyle having the highest compensation of $8,286,100.